BridgeBio Pharma, Inc. (BBIO)
NASDAQ: BBIO · Real-Time Price · USD
81.99
-0.08 (-0.10%)
Aug 5, 2026, 4:00 PM EDT - Market closed
BridgeBio Pharma Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $111 | Buy | Maintains | $111 | +35.38% | Aug 3, 2026 |
| William Blair | William Blair | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Aug 3, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $120 | Buy | Reiterates | $120 | +46.36% | Jul 24, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains $101 | Buy | Maintains | $101 | +23.19% | Jul 22, 2026 |
| Citi | Citi | Hold Reiterates $82 → $93 | Hold | Reiterates | $82 → $93 | +13.43% | Jul 16, 2026 |
| Barclays | Barclays | Buy Reiterates $157 | Buy | Reiterates | $157 | +91.49% | Jul 8, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $100 | Buy | Maintains | $100 | +21.97% | Jul 7, 2026 |
| Jefferies | Jefferies | Buy Maintains $100 | Buy | Maintains | $100 | +21.97% | Jul 6, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.